Feature

First Ascent changing the cancer care narrative with functional precision medicine

Closely held First Ascent Biomedical is working to redefine how oncologists select therapies by pairing genomics with a proprietary live-cell testing platform that evaluates how an individual patient’s cancer responds...

January 20, 2026

Feature

In conversation with Leslie Loveless, CEO and managing partner of Slone Partners

For more than two decades, Slone Partners has maintained a dedicated focus on leadership recruitment for life sciences and healthcare organizations. The company’s co-CEO and managing partner, Leslie Loveless, has been...

January 13, 2026

Feature

PetVivo improving the lives of pets and athlete animals through joint health and mobility

PetVivo Holdings (PetVivo Animal Health) (OTCQX: PTEV; OTCID: PETVW) is adapting human regenerative therapies for the management of osteoarthritis (OA) and other joint disorders in companion and athlete animals. The...

January 6, 2026

Feature

Aqua Medical reversing the metabolic clock with innovative vapor ablation technology

Closely held Aqua Medical is advancing therapy for gastrointestinal (GI) and metabolic diseases—including Type 2 diabetes—using its disruptive, transoral, outpatient vapor-based endoscopic ablation platform.

December 16, 2025

NEWS

Just a few of the companies we’ve highlighted along the way

Giving healthcare companies and their stories the exposure they deserve.

First Ascent changing the cancer care narrative with functional precision medicine

In conversation with Leslie Loveless, CEO and managing partner of Slone Partners

PetVivo improving the lives of pets and athlete animals through joint health and mobility

Aqua Medical reversing the metabolic clock with innovative vapor ablation technology

NEWS

QTI inks distribution agreement with Al Naghi for UAE

BioNxt reports superior bioavailability of cladribine sublingual ODF

MediPharm appoints Greg Hunter interim CEO

Arch names Dr. Patrick Vink as chairman of BOD

Profusa initiates first commercial revenue with healthcare research offerings launch

GT submits IND for GTB-5550 TriKE in solid tumors

Frontiers in Oncology to publish BioMark’s research on ML model for lung cancer detection

Mount Sinai becomes first in NYC to deliver incision-free, MRI-guided prostate treatment with Profound’s TULSA-PRO

cbdMD acquires Bluebird Botanicals

Just a few of the companies we’ve highlighted along the way

Subscribe